Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data Preprint Paper. Abstract Contemporary deep learning approaches still struggle to bring a useful improvement in the field of drug discovery due to the challenges of sparse, noisy and...
Practical Applications of Deep Learning to Imputation of Drug Discovery Data Video Held on 28 April 2020. This webinar was presented by our guest Julian Levell (Constellation Pharmaceuticals) and Ben Irwin (Optibrium). We discussed limitations of pharmaceutical data...
Predicting Reactivity to Drug Metabolism: Beyond P450s – Modelling FMOs and UGTs Video Held on 31 March 2020. After the success of the current P450 models it is time to introduce additional enzyme systems to StarDrop and include enzymes from both modification and...
CAMBRIDGE, UK, 01 April, 2020 – Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a unique Artificial Intelligence (AI) toolset, today announced they have reached a further...
Recent Comments